60 mg tirzepatide – Research Peptide Tirzepatide 60 mg - SEMPICA

Higher concentration: 10mg plus 2mL bacteriostatic water Adding only 2mL creates a concentration of 5mg per mL

The 2019 PIONEER-6 Phase 3a trial was a non-inferiority trial designed to test the cardiac and renal outcomes of patients with T2D receiving daily oral semaglutide

WATER, METHYLPROPANEDIOL, GLYCERIN, BETA-GLUCAN, DIMETHICONE, NIACINAMIDE, CYCLOPENTASILOXANE, BETAINE, POLYGLYCERIN-3, ALGAE EXTRACT, ECLIPTA LEAF EXTRACT, CENTELLA EXTRACT, FIG FRUIT EXTRACT, LICORICE EXTRACT, PANAX GINSENG EXTRACT, ULMUS DAVIDIANA EXTRACT, CAUDATUS SEED EXTRACT, LECITHIN, KERNEL OIL, SODIUM ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER, SODIUM POLYACRYLATE, ETHYLHEXYL STEARATE, ISOHEXADECANE, PANTHENOL, DIMETHICONOL, BUTYLENE GLYCOL, GLUTATHIONE (1000PPM), RICE FERMENT, SORBITAN OLEATE, TRIETHOXYCAPRYLYLSILANE, TRIDECETH-6, SQUALANE, FRUCTOOLIGOSACCHARIDES, HYDROGENATED POLYSOBUTENE, DISODIUM EDTA, ISONONYL ISONONANOATE, POLYGLYCERYL-10 STEARATE, CETEARYL ALCOHOL, STEARIC ACID, SHEA BUTTER, POLYGLYCERYL-2 DIPOLYHYDROXYSTEARATE, HYALURONIC ACID, INULIN LAURYL CARBAMATE, PEARL POWDER, CARBOMER, CERAMIDE NP, DISODIUM STEAROYL GLUTAMATE, PALMITOYL PENTAPEPTIDE-4, POLYSORBATE 80, POLYSORBATE 20, FRANGRANCE, 1,2-HEXANEDIOL, HYDROXYACETOPHENONE, TITANIUM DIOXIDE (CI 77891) *** Ingredients are subject to change at the manufacturer's discretion

Selectie en screening We starten direct met de zoektocht naar de perfecte match voor uw team